Yu Hui Won

Dr. Yu Hui Won


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Korean Circulation Journal
Verified
Journal Article
Open access
CKChul Kim
Chul Kim
JSJidong Sung
Jidong Sung
WKWon-Seok Kim
Won-Seok Kim
GLGoo Joo Lee
Goo Joo Lee
SJSungju Jee
Sungju Jee
SKSoon Kim
Soon Kim
Kim C, et al. Korean Circ J. 2018 Aug;49:e129. https://doi.org/10.4070/kcj.2019.0194

1 January 2017 in Annals of Rehabilitation Medicine
Verified
Journal Article
Open access
PDF file
NKNam-Sik Kim
Nam-Sik Kim
JSJeong-Hwan Seo
Jeong-Hwan Seo
MKMyoung-Hwan Ko
Myoung-Hwan Ko
SPSung-Hee Park
Sung-Hee Park
SKSeong-Woong Kang
Seong-Woong Kang
YWYu Hui Won
Yu Hui Won
Kim NS, et al. Ann Rehabil Med. 2017 Aug;41(4):659-666. https://doi.org/10.5535/arm.2017.41.4.659

16 June 2019 in Pain Research and Management
Verified
Journal Article
Open access
PDF file
EKEu-Deum Kim
Eu-Deum Kim
YWYu Hui Won
Yu Hui Won
SPSung-Hee Park
Sung-Hee Park
JSJeon-Hwan Seo
Jeon-Hwan Seo
DKDa-Sol Kim
Da-Sol Kim
Gi-Wook KimGi-Wook Kim
Gi-Wook Kim
Objective. Studies regarding the combination of ultrasound and transcutaneous electrical nerve stimulation (TENS) are rarely reported. In this study, we aimed to elucidate the efficacy and safety of a stimulator using low-intensity pulsed ultrasound (LIPUS) combined with TENS in patients with painful knee osteoarthritis (OA). We evaluated the effectiveness of this therapy against pain, physical function, and cartilage regeneration. Moreover, we aim to prove the superiority of the effects of LIPUS combined with TENS therapy compared with only TENS therapy.Methods. Of the 40 included patients, aged 45–85 years with painful knee OA, 20 patients received only TENS therapy and 20 patients received LIPUS combined with TENS therapy for 8 weeks (a total of more than 80 treatment sessions). We evaluated visual analogue scale (VAS), Western Ontario and McMaster Universities (WOMAC) osteoarthritis index, MOS 36-Item Short-Form Health Survey (SF-36), and femoral articular cartilage (FAC) thickness. The evaluation was performed at three visits: visit 1 (V1, pretreatment, within 28 days after screening), visit 2 (V2, posttreatment period 1, ±3 days after treatment), and visit 3 (V3, posttreatment period 2, 21 ± 3 days after treatment).Results. We expected that LIPUS combined with TENS therapy would be superior to only TENS therapy. However, there was no significant difference between the two therapies. In the within-group comparison, both treatments (only TENS therapy and LIPUS with TENS therapy) demonstrated statistical differences from baseline values for pain and physical function outcomes. FAC thickness showed no significant differences after treatment in both groups.Conclusion. The effects of a stimulator using LIPUS with TENS on pain relief and functional improvement were not superior to the only TENS therapy. Cartilage regeneration, which was expected as an additional benefit of LIPUS, was also not significantly evident. Therefore, further investigation is warranted to determine whether the combination therapy is beneficial. This trial is registered withKCT0003883.

1 January 2023 in Brain & Neurorehabilitation
Verified
Journal Article
Open access
PDF file
ELEun Hee Lim
Eun Hee Lim
DKDa-Sol Kim
Da-Sol Kim
YWYu Hui Won
Yu Hui Won
SPSung-Hee Park
Sung-Hee Park
JSJeong-Hwan Seo
Jeong-Hwan Seo
Gi-Wook KimGi-Wook Kim
Gi-Wook Kim
Lim EH, et al. Brain Neurorehabil. 2023 Mar;16(1):e4. https://doi.org/10.12786/bn.2023.16.e4

30 June 2019 in Annals of Rehabilitation Medicine
Verified
Journal Article
Open access
PDF file
CKChul Kim
Chul Kim
JSJidong Sung
Jidong Sung
JLJong-Young Lee
Jong-Young Lee
WKWon-Seok Kim
Won-Seok Kim
GLGoo Joo Lee
Goo Joo Lee
SKSoon Kim
Soon Kim
Though clinical practice guidelines (CPGs) for cardiac rehabilitation (CR) are an effective and widely used treatment method worldwide, they are as yet not widely accepted in Korea. Given that cardiovascular disease is the second leading cause of death in Korea, it is urgent that CR programs be developed. In 2008, the Government of Korea implemented CR programs at 11 university hospitals as part of its Regional Cardio-Cerebrovascular Center Project, and three additional medical facilities will be added in 2019. In addition, owing to the promotion of CR nationwide and the introduction of CR insurance benefits, 40 medical institutions nationwide have begun CR programs even as a growing number of medical institutions are preparing to offer CR. The purpose of this research was to develop evidence-based CPGs to support CR implementation in Korea. This study is based on an analysis of CPGs elsewhere in the world, an extensive literature search, a systematic analysis of multiple randomized control trials, and a CPG management, development, and assessment committee comprised of 33 authors-primarily rehabilitation specialists, cardiologists, and thoracic surgeons in 21 university hospitals and two general hospitals. Twelve consultants, primarily rehabilitation, sports medicine, and preventive medicine specialists, CPG experts, nurses, physical therapists, clinical nutritionists, and library and information experts participated in the research and development of these CPGs. After the draft guidelines were developed, three rounds of public hearings were held with staff members from relevant academic societies and stakeholders, after which the guidelines were further reviewed and modified. CR involves a more cost-effective use of healthcare resources relative to that of general treatments, and the exercise component of CR lowers cardiovascular mortality and readmission rates, regardless of the type of coronary heart disease and type and setting of CR. Individualized CR programs should be considered together with various factors, including differences in heart function and lifestyle, and doing so will boost participation and adherence with the CR program, ultimately meeting the final goals of the program, namely reducing the recurrence of myocardial infarction and mortality rates.

Verified
Journal Article
Open access
PDF file
YWYu Hui Won
Yu Hui Won
Yoon Soo ChoYoon Soo Cho
Yoon Soo Cho
SJSo Young Joo
So Young Joo
Cheonghoon SeoCheonghoon Seo
Cheonghoon Seo
We performed pulmonary function (PF) tests and factors affecting PF evaluation in 120 patients with inhalation injury to evaluate the effects of pulmonary rehabilitation (PR) in burn patients with inhalation injury. Patients were randomized into pulmonary rehabilitation (PR) group and conventional rehabilitation (CON) group. PF tests, including forced vital capacity (FVC), 1-s forced expiratory volume FEV1), maximum voluntary ventilation (MVV), and respiratory muscles strength (maximal expiratory pressure (MEP) and maximal inspiratory pressure (MIP)), were measured by mouth pressure meter in the sitting position. Diffusing capacity for carbon monoxide (DLco) was determined by the single-breath carbon monoxide technique. Peak cough flow (PCF) was measured by a peak flow meter. Diaphragmatic mobility (DM) was evaluated on anteroposterior fluoroscopy. All evaluations were performed in all groups at baseline and after 12 weeks. There were no differences in evaluations between the PR group and CON group before the intervention. There were significant improvements in the PCF and MIP (%) changes, taken before and after rehabilitation in the PR group, compared with the changes in the CON group (p = 0.01, and p = 0.04). There were no significant changes in the other parameters in the PR group compared with the changes in the CON group (p > 0.05). There were significant differences in DLco (%), MIP, MIP (%), and DM between the PR group and the CON group (p = 0.02, p = 0.005, and p = 0.001) after 12 weeks of rehabilitation. There were no differences between the PR group and CON group after 12 weeks rehabilitation in the other parameters (p > 0.05). PR for patients with major burns and smoke inhalation induced improved PCF, MIP, MIP (%), DLco (%), and DM. These results show that PR should be a fundamental component of the treatment program for patients with burns.